TLR9 and melanoma: Zeng et al. encapsulated the melanoma antigen peptide tyrosinase–related protein 2 (Trp2) as an antigen and toll-like receptor-9 (TLR-9) agonist CpG oligodeoxynucleotides (CpG ODN) as an adjuvant into a nanovaccine platform.